The Incubator

Startup seeks to change the way organizations raise money online

A Sioux Falls startup is trying to change the way organizations raise money online.

8 years ago

1 Million Cups Unplugged aims to build startups, community

Part of the revamped 1 Million Cups includes a monthly stop at Zeal with a focus on new-business ownership.

8 years ago

International animal genetics leader opens its largest lab in Sioux Falls

The operation started with little fanfare last fall, but what’s happening inside its lab could bring dozens of biotech jobs to Sioux Falls and improve animal genetics for farmers worldwide.

8 years ago
Matthew Paulson

Paulson to bring passion for entrepreneurship to new Zeal role

Entrepreneur, author and angel investor Matthew Paulson is one of several new board members at the Zeal Center for Entrepreneurship.

8 years ago

South Dakota Legislature passes significant bioscience bill

With a unanimous vote in the House and Senate, South Dakota became the latest state to endorse a biologics substitution law.

8 years ago
MTS

From business strategy to lean techniques, this office serves businesses of all sizes

Here’s the first thing to know about South Dakota Manufacturing & Technology Solutions: It’s not just for manufacturers.

8 years ago

Swiss company acquires S.D. biotech firm

One of the world’s largest inspection, verification, testing and certification companies has acquired a thriving South Dakota-based bioscience company.

8 years ago

Avera to enroll world’s first patients in new lung cancer trial

Avera will be the first in the world to enroll lung cancer patients in a clinical trial that is part of an international collaboration.

8 years ago

Thinking of starting a business in 2018? Read this first

Potential entrepreneurs, is this the year you go for it? If you’re entering 2018 with business ownership as your New Year’s resolution, this guide from the Zeal Center for Entrepreneurship is a must-read.

8 years ago

SAB: First MERS treatment appears safe in clinical trial

The anti-MERS immunotherapy developed by Sioux Falls biotech company SAB Biotherapeutics Inc. appears safe in phase 1 clinical trials, the company announced.

8 years ago

News Tip

Have a business news item to share with us?

Scroll to top